Session 6: MS Disease Modifying Therapies (60 min)
Faculty & CME/CNE Information
Activity Release Date: November 22, 2016 Activity Expiration Date: November 22, 2017 Estimated Time to Complete Activity: 60 minutes Media: Internet
Patricia K. Coyle, MD, FAAN, FANA
Professor and Vice Chair of Clinical Affairs
Director of the MS Comprehensive Care Center
Stony Brook University Medical Center
Stony Brook, New York
Stephanie Agrella, MSN, APRN, ANP-BC, MSCN
Director of Clinical Services
Multiple Sclerosis Clinic of Central Texas
Central Texas Neurology Consultants
Round Rock, Texas
This activity has been developed with the need to provide clinicians who manage patients with multiple sclerosis (MS) with up-to-date information on clinical advances in the diagnosis, treatment, and management of patients with the disease.
Upon completion of this series, participants should be able to:
Identify the latest research and clinical information available in the literature with regard to MS diagnosis, treatment, and monitoring
Review current and emerging disease-modifying therapies
The target audience for this activity is neurologists, nursing professionals, physician assistants, rehabilitation professionals, mental health specialists, case workers and other healthcare providers involved in the management of patients with MS.
Accreditation and Credit Statements
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Consortium of Multiple Sclerosis Centers (CMSC), Nurse Practitioner Alternatives (NPA), and Catamount Medical Education. CMSC is accredited by the ACCME to provide continuing medical education for physicians.
CMSC designates this online activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Practitioner Alternatives is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. NPA designates this online activity for a maximum of 1.0 continuing nursing education credits. Laurie Scudder, DNP, NP has served as nurse planner for this activity. She has disclosed no relevant financial relationships.
This series is supported by educational grants from Sanofi Genzyme, Mallinckrodt Pharmaceuticals, and Medtronic.
Instructions for Participation and Credit
There are no fees for participating and receiving credit for this activity. During the period that the activity is available for credit, participants must 1) read the CME/CNE information; 2) complete the pre-test; 3) view the entire video; and 4) complete both the post-test and the evaluation form.
A score of at least 3 out of 4 questions correct must be achieved on the post-test to successfully complete the activity. If you do not receive a passing score, you will receive a message notifying you that you did not pass the post-test. You may retake the post-test until successful. Following the post-test, click on “Submit” and once you have passed, you may click on “Claim CME/CNE Credit”. The evaluation form will appear and upon completing this step, click on “Submit” and your certificate will be emailed to you immediately.
This activity is best viewed using Internet Explorer 11.0 or higher, Google Chrome 53.0 or higher, Firefox 48.0 or higher. For interactive content, a broadband connection is required. For all CME/CNE activities featuring audio you must have a sound card and speakers.
Activity Staff Disclosures
June Halper, MSN, APN-C, MSCN, FAAN, has no relevant financial relationships to disclose. All other planners, reviewers, staff, or other members of the Continuing Professional Education Committee at the Consortium of Multiple Sclerosis Centers who control content have no relevant financial relationships to disclose.
The planners, reviewers, and staff at Nurse Practitioner Alternatives who control content have no relevant financial relationships to disclose.
The planners, reviewers, editors, staff, CME committee, or other members at Catamount Medical Education who control content have no relevant financial relationships to disclose.
The following faculty have indicated they have relationships with industry to disclose relative to the content of this CE activity:
Patricia K. Coyle, MD has served as a consultant for AbbVie, Accordant, Acorda, Bayer, Biogen, Genentech/Roche, Genzyme, Mallinckrodt, Novartis, Serono, and Teva and has received grants/research support from Actelion, Genentech/Roche, Novartis, and Opexa. Dr. Coyle has also conducted contracted research for Actelion, Novartis, and Opexa.
Stephanie Agrella, MSN, APRN, ANP-BC, MSCN has served as a consultant for Sanofi Genzyme and Biogen, and on the Speakers Bureau for Acorda, Sanofi Genzyme, Teva, and Serono.
It is the policy of CMSC, NPA, and Catamount Medical Education to ensure balance, independence, objectivity, and scientific rigor in all its sponsored educational activities. All faculty, activity planners, content reviewers, and staff participating in this activity have disclosed to the participants any significant financial interest or other relationship with manufacturer(s) of any commercial product(s)/device(s) and/or provider(s) of commercial services included in this educational activity. The intent of this disclosure is not to prevent a person with a relevant financial or other relationship from participating in the activity, but rather to provide participants with information on which they can base their own judgments. CMSC, NPA, and Catamount Medical Education have identified and resolved any and all conflicts of interest prior to the release of this activity.
Disclosure of Unapproved Uses
CMSC, NPA, and Catamount Medical Education require CE faculty (speakers) to disclose to the attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty in this activity may discuss information about pharmaceutical agents that is outside of US Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.
Catamount Medical Education, LLC, respects your privacy. All personal information that is provided to Catamount Medical Education, LLC, is protected and will not be sold to a third party for commercial purposes. All personally identifiable information contained in the Catamount Medical Education, LLC, registration databases is treated as confidential and will be used only for the purposes stated in this policy, except where required by law. Catamount Medical Education, LLC, maintains user databases that contain mailing and user profile information as well as a record of the CME activities viewed and the post-test and evaluation results for CME/CNE credit. This information is provided to activity collaborators for the purposes of CME/CNE recordkeeping. By participating in this activity, you agree that Catamount Medical Education, LLC, has full permission to provide this information.
For each visitor to this Web site, our Web server automatically recognizes information such as the visitor’s IP address. We use this information to capture partial answers to interactive questions and evaluations. We do not set any cookies on your computer. Catamount Medical Education, LLC, safeguards against the loss, misuse or alteration of information that we have collected in this activity.
If you have questions about this CME/CNE activity, please contact Catamount Medical Education, LLC, at firstname.lastname@example.org or at 860-661-4159.